Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide

被引：0
|
作者：
Heute, D. R. [1 ]
Dobrozemsky, G. [1 ]
Traub, T. [1 ]
Warwitz, B. [1 ]
von Guggenberg, E. [1 ]
Gabriel, M. [1 ]
Virgolini, I. [1 ]
机构：
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Minczeles, Noemie S.
    Bos, Eelke M. M.
    de Leeuw, Reinoud C. C.
    Kros, Johan M. M.
    Konijnenberg, Mark W. W.
    Bromberg, Jacoline E. C.
    de Herder, Wouter W. W.
    Dirven, Clemens M. F.
    Hofland, Johannes
    Brabander, Tessa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1195 - 1204
  • [32] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Peter Frøhlich Staanum
    Anders Floor Frellsen
    Marie Louise Olesen
    Peter Iversen
    Anne Kirstine Arveschoug
    EJNMMI Physics, 8
  • [33] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Sejin Ha
    Yong-il Kim
    Jungsu S. Oh
    Changhoon Yoo
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    EJNMMI Physics, 11
  • [34] Radiation dosimetry and radiotherapy planning for peptide receptor radionuclide therapy with 177Lu-DOTA-Tyr3-octreotate (Lu-O) in humans
    Kooij, PPM
    Konijnenberg, MW
    Kwekkeboom, DJ
    Bakker, WH
    Krenning, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1026 - 1026
  • [35] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Ha, Sejin
    Kim, Yong-il
    Oh, Jungsu S.
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    EJNMMI PHYSICS, 2024, 11 (01)
  • [36] Patient-specific pharmacokinetics and dosimetry over multiple therapy cycles during 177Lu-based radionuclide therapy: a study for 177Lu-DOTATATE and 177Lu-PSMA
    Gosewisch, A.
    Ermoschkin, L.
    Ilhan, H.
    Todica, A.
    Vamacka, L.
    Bartenstein, P.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S270 - S271
  • [37] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Noémie S. Minczeles
    Eelke M. Bos
    Reinoud C. de Leeuw
    Johan M. Kros
    Mark W. Konijnenberg
    Jacoline E. C. Bromberg
    Wouter W. de Herder
    Clemens M. F. Dirven
    Johannes Hofland
    Tessa Brabander
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1195 - 1204
  • [38] Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy
    Abbott, Amanda
    Jacene, Heather
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2018, 46 (03) : 245 - 246
  • [39] Peptide receptor radionuclide therapy using somatostatin receptor antagonists: first results of biodistribution and dosimetry of Lu-177 DOTA-LM3 compared to Lu-177 DOTATOC
    Schuchardt, Christiane
    Kulkarni, Harshad
    Singh, Aviral
    Mueller, Dirk
    Fani, Melpomeni
    Maecke, Helmut
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [40] Assessment of Occupational Radiation Exposure During Administration of [177Lu]Lu-DOTA-TATE Using Active and Passive Dosimetry
    Riveira-Martin, M.
    Struelens, L.
    Iglesias, J. Munoz
    Schoonjans, W.
    Alonso, J. M. Nogueiras
    Tabuenca, O.
    Gomez, F. J. Salvador
    Medina, A. Lopez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S226 - S227
12345